LESAKA TECHNOLOGIES, INC.
CONSOLIDATED STATEMENT
S
OF CASHFLOWS
for the years ended June 30, 2026, 2025 and 2024
F
-10
2026
2025
2024
(In thousands)
Cash flows from operating activities
Net income (loss)
(A)
$
2,512
$
(91,087)
$
(18,515)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating
activities:
Depreciation and amortization
47,346
33,721
23,665
Impairment loss (Note 10)
4,035
18,863
-
Movement in allowance for credit losses
12,796
8,011
5,158
Fair value adjustment related to financial liabilities
(238)
(120)
(853)
Change in fair value of equity securities (Note 6 and 9)
(2,593)
59,828
-
Other income
(3,883)
-
-
Loss on disposal of equity securities (Note 3)
730
-
-
Loss on impairment/ disposal of equity-accounted investment (Note 9)
584
161
-
Gain on deconsolidation of subsidiary
(848)
-
-
(Profit) Loss on disposal of property, plant and equipment
(316)
13
(305)
Stock-based compensation charge (Note 17)
6,969
9,550
7,911
(Earnings) Loss from equity-accounted investments (Note 9)
(215)
(114)
1,279
Reversal of allowance for doubtful loans receivable
(1,500)
-
(250)
Dividends received from equity-accounted investments
105
96
95
Interest payable
20
4,723
1,119
Facility fee amortized (Note 12)
413
429
443
Increase (Decrease) in income taxes payable
402
485
(400)
Deferred tax benefit
(A)
(9,451)
(21,739)
(2,712)
Changes in net working capital
Decrease (Increase) in accounts receivable (Note 20)
3,500
1,081
(10,873)
Increase in finance loans receivable (Note 20)
(34,421)
(34,614)
(10,029)
Decrease in inventory
6,704
169
9,840
Increase (Decrease) in accounts payable and other payables
(A)
19,793
(12,164)
23,216
Deferred consideration included in other payables (Note 3 and Note 13)
-
13,586
-
Net cash provided by (used in) operating activities
52,444
(9,122)
28,789
Cash flows from investing activities
Capital expenditures
(20,646)
(17,199)
(12,665)
Proceeds from disposal of property, plant and equipment
1,849
1,938
1,565
Acquisition of intangible assets
(4,403)
(3,900)
(294)
Acquisitions, net of cash acquired (Note 3)
(11,117)
(12,946)
(1,583)
Proceeds from disposal of equity securities (Note 6 and 9)
2,971
16,441
-
Investment in equity securities
(450)
-
-
Cash disposed on disposal of subsidiary
(165)
-
-
Proceeds from disposal of equity-accounted investment (Note 9)
-
-
3,508
Repayment of loans by equity-accounted investments
-
-
250
Acquisition of insurance entity investments
(4,598)
-
-
Net change in settlement assets
10,822
4,324
(7,196)
Net cash used in investing activities
(25,737)
(11,342)
(16,415)
Cash flows from financing activities
Proceeds from bank overdraft (Note 12)
123,712
98,616
182,990
Repayment of bank overdraft (Note 12)
(129,417)
(90,309)
(199,642)
Long-term borrowings utilized (Note 12)
6,949
190,061
23,728
Repayment of long-term borrowings (Note 12)
(13,741)
(149,511)
(20,073)
Non-refundable deal origination fees/ guarantee fees (Note 12)
(285)
(970)
-
Repurchase of shares of common stock and treasury stock (Note 14)
(339)
(13,660)
(1,495)
Proceeds from exercise of stock options
63
116
165
Acquisition of non-controlling interests (Note 14)
(3,538)
-
-
Dividends paid to non-controlling interest
-
(432)
-
Net change in settlement obligations
(10,390)
(4,179)
7,214
Net cash (used in) provided by financing activities
(26,986)
29,732
(7,113)
Effect of exchange rate changes on cash
5,178
1,453
2,025
Net increase in cash, cash equivalents and restricted cash
4,899
10,721
7,286
Cash, cash equivalents and restricted cash – beginning of period
76,639
65,918
58,632
Cash, cash equivalents and restricted cash – end of period (Note 20)
$
81,538
$
76,639
$
65,918
(A) Revised to correct the errors discussed in Note 1.
See accompanying notes to consolidated financial statements
エドガーで原本を確認する
